©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Ginger Constantine
FDA Fast-Tracks PleoPharma’s Investigational New Drug for Mitigation Cannabis Use Disorder Withdrawal
PHOENIXVILLE, Pa. -- The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, PleoPharma Inc.'s investigational new drug (IND) application for...
PleoPharma Receives Two U.S. Patents
PHOENIXVILLE, Pa. -- PleoPharma Inc., a privately held company focused on Cannabis-related health issues, has been issued two U.S. patents with broad claims relating to...
PLEOPHARMA,INC. REPORTS POSITIVE PHASE 2b CLINICAL TRIAL DATA FOR MITIGATION OF CANNABIS WITHDRAWAL
PHOENIXVILLE, Pa. -- PleoPharma Inc., a privately held company focused on cannabis related health issues, announced Phase 2b study results for its lead drug candidate, PP-01,...